A detailed history of Tfc Financial Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Tfc Financial Management holds 40,955 shares of MRK stock, worth $4.06 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
40,955
Previous 40,365 1.46%
Holding current value
$4.06 Million
Previous $5 Million 6.94%
% of portfolio
0.74%
Previous 0.88%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$111.15 - $128.97 $65,578 - $76,092
590 Added 1.46%
40,955 $4.65 Million
Q2 2024

Jul 23, 2024

SELL
$123.8 - $132.96 $62,519 - $67,144
-505 Reduced 1.24%
40,365 $5 Million
Q1 2024

Apr 30, 2024

SELL
$113.24 - $131.95 $51,524 - $60,037
-455 Reduced 1.1%
40,870 $5.39 Million
Q4 2023

Jan 25, 2024

SELL
$100.18 - $109.02 $17,130 - $18,642
-171 Reduced 0.41%
41,325 $4.51 Million
Q3 2023

Oct 23, 2023

BUY
$102.95 - $114.33 $30,782 - $34,184
299 Added 0.73%
41,496 $4.27 Million
Q2 2023

Aug 07, 2023

BUY
$108.61 - $118.38 $6,951 - $7,576
64 Added 0.16%
41,197 $4.75 Million
Q1 2023

May 08, 2023

BUY
$102.94 - $114.86 $39,837 - $44,450
387 Added 0.95%
41,133 $4.38 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $34,276 - $43,947
-392 Reduced 0.95%
40,746 $4.52 Million
Q3 2022

Oct 21, 2022

SELL
$84.53 - $94.96 $16,906 - $18,992
-200 Reduced 0.48%
41,138 $3.54 Million
Q2 2022

Aug 03, 2022

SELL
$83.49 - $94.64 $17,616 - $19,969
-211 Reduced 0.51%
41,338 $3.77 Million
Q4 2021

Feb 02, 2022

BUY
$72.28 - $90.54 $64,835 - $81,214
897 Added 2.21%
41,549 $3.18 Million
Q2 2021

Jul 29, 2021

SELL
$70.31 - $77.77 $14,624 - $16,176
-208 Reduced 0.51%
40,652 $3.16 Million
Q3 2020

Nov 12, 2020

BUY
$73.18 - $82.95 $2.99 Million - $3.39 Million
40,860 New
40,860 $3.39 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Tfc Financial Management Portfolio

Follow Tfc Financial Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tfc Financial Management, based on Form 13F filings with the SEC.

News

Stay updated on Tfc Financial Management with notifications on news.